Endo International plc (NASDAQ:ENDP) saw an upside of 1.46% on Monday at $3.48 after adding $0.05. The 5-day average trading volume is 7,138,633 shares of the company’s common stock. It has gained $3.71 in the past week and touched a new high 1 time within the past 5 days. An average of 16,034,169 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 11,841,993.
ENDP’s 1-month performance is 63.33% or $1.38 on its low of $2.07 reached on 09/09/21. The company’s shares have touched a 52-week low of $1.94 and high of $10.89, with the stock’s rally to the 52-week high happening on 02/18/21. YTD, ENDP has lost -52.23% or -$3.65 and has reached a new high 7 times. However, the current price is down -68.04%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Mar 15, 203 days have gone by since the last insider trading activity for Endo International plc (ENDP). MONTAGUE WILLIAM P (Director) most recently sold 9,033 shares at $8.68 per share on Mar 15. This transaction cost the insider $78,406. Director, Cooke Shane, sold 17,290 shares at a price of $8.65 on Mar 15.
Endo International plc (ENDP) has a trailing price-to-earnings (P/E) ratio of 24.12 for the broader industry and 32.07 for the sector, meaning that investors are optimistic about the stock’s future prospects. The company’s PE ratio for the last five years has touched a high of 18.54 and a low of 7.50. ENDP stock has a beta of 1.10. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.27 while the price to cash flow ratio at 2.14.
Endo International plc’s quick ratio for the period ended June 29 was 1.60, with the current ratio over the same period at 1.80 meaning that ENDP stock is able to fulfill its debt obligations. In terms of profitability, the gross margin trailing 12 months is 54.90%The trailing 12-month EBITDA margin is 38.65% while for the period ending June 29; Endo International plc’s operating margin was 18.50%. The firm’s gross profit as reported stood at $1.46 billion against revenue of $2.9 billion.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected ENDP to announce $0.48 per share in earnings in its latest quarter, but it posted $0.65, representing a 35.40% surprise. EBITDA for the quarter stood at more than $265.63 million. ENDP stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 9.82 billion, with total debt at $8.35 billion. Shareholders hold equity totaling $233.5 million
Let’s look briefly at Endo International plc (ENDP) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 01 October was 68.01% to suggest the stock is trending Neutral, with historical volatility in this time period at 78.32%.
The stock’s 5-day moving average is $3.40, reflecting a +3.68% or $0.13 change from its current price. ENDP is currently trading +63.95% above its 20-day SMA, -35.08% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -29.50% and -37.83% respectively.
Stochastic %K and %D was 72.61% and 70.82% and the average true range (ATR) pointed at 0.31. The RSI (14) points at 60.90%, while the 14-day stochastic is at 83.04% with the period’s ATR at 0.32. The stock’s 9-day MACD Oscillator is pointing at 0.06 and 0.26 on the 14-day charts.
In the most recent analyst report for Endo International plc (NASDAQ: ENDP), Piper Sandler downgraded it to a Neutral rating. They previously had an Overweight rating on the stock. Analysts offering their rating for ENDP stock have a consensus rating for the stock as Hold. Currently, 2 brokerage advisors rate ENDP as a “sell,”, while 6 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is ENDP’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $3.00 and a high of $11.00, with their median price target at $7.00. Looking at these predictions, the average price target given by analysts is for Endo International plc (ENDP) stock is $6.57.